HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

By Reigadas S.   Marcelin A. G.   Houssaïni A.   Yerly S.   Descamps D.   Plantier J. C.   Ruffault A.   Amiel C.   Trabaud M. A.   Flandre Philippe   Fleury H.   Masquelier B.   Roussel C.   Alloui C.   Leguillou-Guillemette H.   Bettinger D.   Pallier C.   Brun-Vezinet F.   Peytavin G.   Pinson P.   Vallet S.   Poveda J. D.   Mirand A.   Krivine A.   Auvray C.   de Rougemont A.   Signori-Schmuck A.   Bocket L.   Rogez S.   Tamalet C.   Schneider V.   Bouvier-Alias M.   Montes B.   Schvoerer E.   Ferré V.   Chaix M. L.   Guinard J.   Haim-Boukobza S.   Soulié C.   Flandre P.   Assoumou L.   Calvez V.   Maillard A.   Morand-Joubert L.   Chaplain C.   Delaugerre C.   Bourlet T.   Bertsch S.   Raymond S.   Marque-Juillet S.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 4, 2013-04 ,pp. : 969-972

Oxford University Press

Access to resources Recommend Favorite

Elvitegravir: an emerging HIV integrase inhibitor

By Shimura Kazuya   Kodama Eiichi  

Future HIV Therapy, Vol. 2, Iss. 5, 2008-09 ,pp. : 411-418

Future Medicine

Access to resources Recommend Favorite

Sequence-Based Predictive Models of Resistance to HIV-1 Integrase Inhibitors: An n-Grams Approach to Phenotype Assessment

By  

Current HIV Research, Vol. 13, Iss. 6, 2015-01 ,pp. : 497-502

Bentham Science Publishers

Access to resources Recommend Favorite

HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries

By  

Current HIV Research, Vol. 15, Iss. 5, 2017-11 ,pp. : 318-326

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir

By  

Current HIV Research, Vol. 12, Iss. 5, 2014-09 ,pp. : 325-338

Bentham Science Publishers

Access to resources Recommend Favorite